BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16678488)

  • 1. Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
    Chiu YL; Greene WC
    Trends Immunol; 2006 Jun; 27(6):291-7. PubMed ID: 16678488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
    Franca R; Spadari S; Maga G
    Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC family proteins: novel antiviral innate immunity.
    Takaori-Kondo A
    Int J Hematol; 2006 Apr; 83(3):213-6. PubMed ID: 16720550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
    Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
    J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system.
    Ehrlich ES; Yu XF
    Int J Hematol; 2006 Apr; 83(3):208-12. PubMed ID: 16720549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
    Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
    J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
    Rose KM; Marin M; Kozak SL; Kabat D
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
    Chiu YL; Greene WC
    Annu Rev Immunol; 2008; 26():317-53. PubMed ID: 18304004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
    Jost S; Turelli P; Mangeat B; Protzer U; Trono D
    J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G & HTLV-1: inhibition without deamination.
    Strebel K
    Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
    Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
    Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
    Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
    Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3 inhibits mouse mammary tumour virus replication in vivo.
    Okeoma CM; Lovsin N; Peterlin BM; Ross SR
    Nature; 2007 Feb; 445(7130):927-30. PubMed ID: 17259974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
    Bishop KN; Holmes RK; Malim MH
    J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
    Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
    Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
    Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
    J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA deaminases AID and APOBEC3G act processively on single-stranded DNA.
    Pham P; Chelico L; Goodman MF
    DNA Repair (Amst); 2007 Jun; 6(6):689-92; author reply 693-4. PubMed ID: 17291835
    [No Abstract]   [Full Text] [Related]  

  • 19. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
    Xiao Z; Ehrlich E; Luo K; Xiong Y; Yu XF
    FASEB J; 2007 Jan; 21(1):217-22. PubMed ID: 17135358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
    Gallois-Montbrun S; Kramer B; Swanson CM; Byers H; Lynham S; Ward M; Malim MH
    J Virol; 2007 Mar; 81(5):2165-78. PubMed ID: 17166910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.